Physician

Stephen D Markewich, MD

According to 2025 Medicare claims, Stephen Markewich, MD (NPI: 1295959823) practices pain management in the Anchorage, AK market, with the plurality of this provider's patient population coming from Matanuska-Susitna, AK. This provider's primary affiliated billing organization is MEDICAL GROUP OF ALASKA (NPI: 1174882971; TIN: 473568350) and primary practice location at 99654-7422.

Markewich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 860 traditional Medicare patients, billed 46,478 HCPCS/CPT codes, and received $767,694 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 284 prescription claims across 151 beneficiaries totaling $24,728 in drug costs, led by Botox (Onabotulinumtoxina). DME data shows 12 claims. Open Payments data shows 55 records totaling $2,037. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $112,427 to $767,694. Similarly, Part D prescription costs have risen steadily, from $2,867 to $24,728. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,286 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	574	2,358	$112,427
2016	623	2,601	$114,299
2017	612	2,679	$150,362
2018	579	2,238	$137,555
2019	793	4,108	$188,083
2020	646	2,436	$128,267
2021	321	1,948	$115,741
2022	731	6,176	$494,401
2023	860	14,142	$1,127,019
2024	860	46,478	$767,694

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	78	145	$2,867
2016	115	209	$8,512
2017	70	119	$7,377
2018	31	40	$2,951
2019	24	33	$591
2020	18	28	$287
2021	95	202	$13,133
2022	255	671	$49,539
2023	177	361	$30,306
2024	151	284	$24,728

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$1,286
2017	N/R	22	$830
2018	N/R	37	$1,654
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	32	32	$22,470
2023	21	21	$21,470
2024	12	12	$12,438

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	640	1,820	$119
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	557	1,132	$87
80307	Testing for presence of drug, by chemistry analyzers	338	427	$60
J1100	Injection, dexamethasone sodium phosphate, 1 mg	259	4,327	$0
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	287	20,068	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Botox	Onabotulinumtoxina	15	1,260	$17,451
Celecoxib	Celecoxib	15	450	$1,006
Oxycodone Hcl	Oxycodone Hcl	18	520	$625
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	399	$440
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	455	$368

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L0650	Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf	N	12	12	$12,438

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$2,037	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stephen D. Markewich, MD?

Tedicare shows public-source Medicare data for Stephen D. Markewich, MD (NPI 1295959823), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen D. Markewich, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stephen D. Markewich, MD?

Stephen D. Markewich, MD is linked to MEDICAL GROUP OF ALASKA (billing NPI 1174882971) in the available physician profile data.

Does Stephen D. Markewich, MD have Open Payments data?

Stephen D. Markewich, MD has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.